# Qualitative Chunk Sample (random sample)

Please check each item:
- Can it independently answer a simple question?
- Does it include too many unrelated topics?

## [1] source=Livingston_Lancet Commission accepted version.pdf | chars=1531 | ~tokens=468 | chunk_id=251
Q: What could be the possible negative impacts of consuming alcohol for a family member who has Mild Cognitive Impairment?

422. Brayne C, Kelly S. Against the stream: early diagnosis of dementia, is it so desirable? Bjpsych Bull. 2019;43(3):123-5. 423. Gunak MM, Barnes DE, Yaffe K, Li Y, Byers AL. Risk of Suicide Attempt in Patients With Recent Diagnosis of Mild Cognitive Impairment or Dementia. JAMA Psychiatry. 2021;78(6):659-66. 424. Kourtis LC, Regele OB, Wright JM, Jones GB. Digital biomarkers for Alzheimer's disease: the ...

## [2] source=fneur-12-644317.pdf | chars=2015 | ~tokens=488 | chunk_id=511
Q: What changes can I make to my loved one's surroundings that may aid in managing continence care for their dementia condition?

Carrarini et al. Managing Agitation in Dementia FIGURE 1 | The ﬁgure depicts the cerebral areas involved in the pathological process of agitation. SPC, superior parietal cortex; dlPFC, dorsolateral pre-frontal cortex; ATL, anterior temporal lobe; OFC, orbitofrontal cortex; ACC, anterior cingulate cortex; LC, locus coeruleus. frequent as 30%. It is important to understand the prevalence of agitation and ...

## [3] source=Livingston_Lancet Commission accepted version.pdf | chars=1320 | ~tokens=434 | chunk_id=266
Q: What would be the most effective treatment options for a family member who has been diagnosed with both dementia and depression?

504. Liu KY, Walsh S, Brayne C, Merrick R, Richard E, Howard R. Evaluation of clinical benefits of treatments for Alzheimer's disease. Lancet Healthy Longev. 2023;4(11):e645-e51. 505. Rubin R. Who Should-and Can-Get Lecanemab, the New Alzheimer Disease Drug? Jama. 2023. 506. Assuncao SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, et al. Meaningful benefits: a framework to assess disease-modifying ...

## [4] source=nihms-1020336.pdf | chars=1660 | ~tokens=476 | chunk_id=624
Q: Can you suggest any tools or templates that we can use to help manage and monitor the daily routine of a family member with MCI or dementia?

potentially inappropriate medication use in older adults. Medsurg Nurs 21, 129–132; quiz 133. [PubMed: 22866431] •• Important update to Beers Criteria from the American Geriatrics Society, highlighting medications that should be prescribed with caution in the older adult population. [51]. Pauszek ME (1991) Propranolol for treatment of agitation in senile dementia. Indiana Med 84, 16–17. [PubMed: 1997597] [52]. ...

## [5] source=fneur-12-644317.pdf | chars=1841 | ~tokens=482 | chunk_id=537
Q: Lately, my loved one with dementia has been having vivid dreams and sometimes even nightmares that feel very real to them. Is this something that’s common with dementia, and should I be concerned?

other forms of dementia, even in the absence of evidence-based support. For instance, AChEIs and memantine failed to provide beneﬁts in FTD patients and actually exacerbated behavioral symptoms (187–189). Alterations of serotoninergic and dopaminergic rather than cholinergic neurotransmission are present in FTD (190), and therefore, SSRIs and antipsychotic drugs have been tested with diﬀerent results. The ...

